Mucinous Carcinoma in a Male: First Documented Case in Nicaragua.

male breast cancer modified radical mastectomy mucinous carcinoma multi-disciplinary teams retro-areolar tumors

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Aug 2024
Historique:
accepted: 24 08 2024
medline: 24 9 2024
pubmed: 24 9 2024
entrez: 24 9 2024
Statut: epublish

Résumé

Breast malignancy in men is an exceedingly rare condition, representing a small fraction of all diagnosed breast cancer cases. The most common histological subtype is invasive ductal carcinoma, while the mucinous type is extremely rare. This pathology has a high mortality rate due to its poor prognosis and diagnosis in advanced stages, often initially overlooked with limited screening. Surprisingly, more men have died from breast cancer than from testicular cancer. This report details a case of invasive mucinous carcinoma in a 75-year-old male who presented with a five-week history of chronic non-productive cough and signs of pleural effusion. A breast magnetic resonance imaging (MRI) revealed a retroareolar breast tumor, and a second-look ultrasound confirmed the presence of a BI-RADS 4C solid nodule. Histopathological and immunohistochemical results were confirmed by ultrasound-guided tru-cut biopsy, identifying invasive mucinous carcinoma and luminal B (HER2+) subtype. Staging studies were negative for metastasis, and a modified radical mastectomy was performed, yielding favorable intraoperative findings. The incidental diagnosis in this patient highlights the necessity of comprehensive imaging in atypical presentations. Despite its rarity, awareness and early detection of mucinous carcinoma are essential for optimizing patient outcomes. This case also underscores the disparity in breast cancer outcomes between low gross domestic product (GDP) and high-GDP countries, emphasizing the need for improved access to diagnostic and therapeutic resources. Enhanced clinical awareness and early detection are crucial for improving outcomes in patients with rare histological subtypes, particularly in underserved regions.

Identifiants

pubmed: 39314558
doi: 10.7759/cureus.67674
pmc: PMC11418925
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Pagination

e67674

Informations de copyright

Copyright © 2024, Altamirano et al.

Déclaration de conflit d'intérêts

Human subjects: Consent was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Auteurs

Gilberto A Altamirano (GA)

Medical Education, Hospital Militar Escuela "Dr. Alejandro Dávila Bolaños", Managua, NIC.

Christopher K Romero (CK)

Medical Education, Hospital Militar Escuela "Dr. Alejandro Dávila Bolaños", Managua, NIC.

Catherine S Moreno Cabrera (CS)

Medical Education, Hospital Militar Escuela "Dr. Alejandro Dávila Bolaños", Managua, NIC.

Lorenzo E Aragón Conrado (LE)

Medical Education, Hospital Militar Escuela "Dr. Alejandro Dávila Bolaños", Managua, NIC.

Classifications MeSH